Health TrialsbyHealthPanel

Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis

ConditionPlantar Fasciitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAnkara City Hospital Bilkent

About this trial

This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis.

A total of 48 patients with chronic plantar fasciitis will be included in this prospective, randomized controlled trial and randomly allocated into two groups: the ESWT group and the ESWT + Kinesio Taping group.

Primary outcome measures include pain severity assessed via the Visual Analog Scale (VAS) for morning and general pain, foot functionality evaluated using the Foot Function Index (FFI), and plantar fascia thickness measured via ultrasonography. Evaluations will be conducted at baseline, immediately post-treatment, and at the 3-month follow-up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Kinesio Taping

    Other intervention

    Kinesiology tape applied twice (once a week for 2 weeks) with mechanical correction and tension

  • Extracorporeal Shock Wave Therapy (ESWT)

    Device

    Patients will receive 3 sessions of focused ESWT at 1-week intervals (1800 to 2000 impulses per session at 0.20-0.30 mJ/mm²

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: ESWT GroupActive comparator 1 intervention
Group B: ESWT + Kinesio Taping GroupExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in Visual Analog Scale (VAS) Score for Pain

Time frame
Baseline, immediately post-treatment, and at 3-month follow-up
2

Change in Foot Function Index (FFI) Score

Time frame
Baseline, immediately post-treatment, and at 3-month follow-up
3

Change in Plantar Fascia Thickness Measured by Ultrasonography

Time frame
Baseline, immediately post-treatment, and at 3-month follow-up

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ankara City Hospital Bilkent

Lead sponsor

Source ClinicalTrials.gov
Apply now